Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsÀngela Deyà‐Martínez, Manfred Fliegauf, Nils Klammer et al.|Journal of Allergy and Clinical Immunology|2020Cited by 127
X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the worldZeinab El-Sayed, Алла Волоха, Ghassan Dbaibo et al.|World Allergy Organization Journal|2019Cited by 118
Variants in <i>STXBP3</i> are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune DysregulationJodie Ouahed, Scott B. Snapper, Judith R. Kelsen et al.|Journal of Crohn s and Colitis|2021Cited by 17
25 MUTATIONS IN STXBP3 CONTRIBUTE TO VERY EARLY ONSET OF IBD, IMMUNODEFICIENCY AND HEARING LOSSJudith R. Kelsen, Claudio G. Giraudo, Jodie Ouahed et al.|Gastroenterology|2018Cited by 2
25 MUTATIONS IN STXBP3 CONTRIBUTE TO VERY EARLY ONSET OF IBD, IMMUNODEFICIENCY AND HEARING LOSSJudith R. Kelsen, Claudio G. Giraudo, Jodie Ouahed et al.|Inflammatory Bowel Diseases|2018Cited by 0